News and Announcements
Kela Surpasses First Release Target of Shares Issued
- Published March 23, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Kela is pleased to announce that we have surpassed our first release target of shares issued.
Our intention is to limit the total issue of shares to 1000 ordinary shares, where by our intended first issue was 750 shares only. With the balance 250 shares to issue later in the year.
We have now reached 850 shares issued and we will be closing this current offer at the end of the march and the remaining shares we will put up for offer again at a later date being August the 25th at a revalued sale price. Please contact us to register your interest in what we anticipate to be short highly sort after offering.
I would also like to announce that we will be exhibiting at our first trade show to the Salon and Beauty Industry this weekend March 25th and 26th at the ‘’beauty expo at the Melbourne Exhibition centre. We will be taking orders and looking for potential distributors in the Salon channel in the Australian market.
Also, our website will be going live end next week and we will be taking orders directly from the public both in Australia and Internationally.
Both the Website launch and the beauty Expo as well as Facebook and Instagram launch this week are in effect a soft launch for the brand, and its anticipated our Major Brand launch with our New Marketing collateral will be mid-May.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
